Talphera TLPH
NASDAQ TLPH
$1.24 +0.01 (+1.23%)
As of: Sep 10, 2026 · 1:39 PM EDT

Talphera (TLPH) Operating Income (2014 - 2026)

Talphera (TLPH) posted Operating Income of -$3.9 million for Q2 2026, up 0.61% on a QoQ basis from -$3.9 million in Q1 2026, and down 6.26% year-over-year from -$4.2 million in Q2 2025.

Analysis

Talphera (TLPH) Operating Income (2014 - 2026) Analysis & Trends

Talphera has reported Operating Income for 13 years, with the latest figure at -$3.9 million in Q2 2026.

  • On a quarterly basis, Operating Income fell 6.26% year-over-year to -$3.9 million in Q2 2026; TTM through Jun 2026 was -$14.7 million, a 10.43% decrease from a year earlier, with the FY2025 full-year figure at -$13.5 million, up 11.59% from the prior year.
  • Operating Income was -$3.9 million for Q2 2026 at Talphera, up from -$3.9 million in the prior quarter.
  • The five-year high for Operating Income was $3.9 million in Q4 2022, with the low at -$13.6 million in Q2 2022.
  • Average Operating Income over 5 years is -$4.3 million, with a median of -$3.9 million recorded in 2026.
  • The sharpest annual moves came in 2022 and 2023: Operating Income jumped 147.71% in 2022, then tumbled 209.82% in 2023.
  • Over 5 years, Operating Income stood at $3.9 million in 2022, then sank by 209.82% to -$4.3 million in 2023, then soared by 30.05% to -$3.0 million in 2024, then slipped by 15.25% to -$3.5 million in 2025, then declined by 13.64% to -$3.9 million in 2026.
  • The last three Operating Income figures came in at -$3.9 million (Q2 2026), -$3.9 million (Q1 2026), and -$3.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 180.02 Bn 176.84 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 131.54 Bn 123.69 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.96 Bn 73.96 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 60.23 Bn 55.04 Bn 1.37 Bn 493.00 Mn
6 Moderna 53.85 Bn 48.72 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 33.13 Bn 29.82 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.88 Bn 30.59 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 29.23 Bn 29.23 Bn 1.16 Mn -365.99 Mn
10 Talphera 93.28 Mn 93.28 Mn - -3.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.92 Mn
Mar 31, 2026 -3.95 Mn
Dec 31, 2025 -3.45 Mn
Sep 30, 2025 -3.42 Mn
Jun 30, 2025 -3.69 Mn
Mar 31, 2025 -2.92 Mn
Dec 31, 2024 -3.00 Mn
Sep 30, 2024 -3.75 Mn
Jun 30, 2024 -4.27 Mn
Mar 31, 2024 -4.24 Mn
Dec 31, 2023 -4.28 Mn
Sep 30, 2023 -3.31 Mn
Jun 30, 2023 -3.97 Mn
Dec 31, 2022 3.90 Mn
Sep 30, 2022 -6.63 Mn
Jun 30, 2022 -13.57 Mn
Mar 31, 2022 -9.00 Mn
Dec 31, 2021 -8.18 Mn
Sep 30, 2021 -8.63 Mn
Jun 30, 2021 -10.02 Mn